Finding Description
Based on observation, interview, record review, review of the controlled substance log titled Individual Patient Controlled Substance Administration Records [IPCSAR], and review of the facility's policies, the facility failed to ensure the proper documentation of controlled substances in accordance with professional standards of practice when nursing staff did not accurately complete and reconcile controlled narcotic record sheets at the time of removal for the A, B, and C Hall medication carts. In multiple instances, the IPCSAR sign out time, which should reflect the actual time the narcotic was removed from the narcotic bubble pack, instead reflected the ordered time and did not correlate with the medication administration time documented on the Medication Administration Record [MAR]. These repeated omissions demonstrated ongoing noncompliance with the required narcotic documentation practices and created an unacceptable risk for diversion and inaccurate medication records and comprised resident safety for 11 of 11 sampled residents, Resident (R) 2, R17, R20, R23, R31, R37, R42, R68, R73, R122, and R127. Additionally, medications were given late, past the scheduled administration time and the parameters for medication administration for 10 of 11 sampled residents, R2, R17, R20, R23, R31, R42, R68, R73, R122, and R127.The findings include:Review of the facility's policy titled, Controlled Substances, revised 11/2024, revealed when a licensed nurse removed a controlled substance for administration, the removal must be documented on the controlled substance record at the time of removal, including the date, time, and amount removed for that resident.Review of the facility's policy titled, Administering Medications, reviewed 04/28/2025, revealed medications were to be given as ordered, including any specified administration times. The policy further stated scheduled medication should be administered within one hour of the scheduled administration time (SAT), unless the prescriber specified a different time frame.1. Observation of the A Hall medication cart with the Director of Nursing (DON) and Licensed Practical Nurse (LPN) 3 on 01/07/2026 at 10:36 AM, revealed LPN3 did not sign out R122's 8:00 AM gabapentin dose at the time it was removed from the bubble pack.During continued observation on 01/07/2026 at 10:48 AM, LPN3 returned to the medication cart and informed the DON she needed to sign R122's IPCSAR. LPN3 stated the medication had been administered at 10:20 AM, and she was only then returning to complete the required sign out documentation.During an immediate interview with LPN3, when questioned by the State Survey Agency (SSA) Surveyor regarding why she did not sign out the medication per policy at the time it was removed from the bubble pack, she stated, I'm signing it out now. When educated by the DON on facility policy, LPN3 did not provide any further explanation and responded by shaking her head and nodding in agreement.Review of the admission Record found in R122's electronic health record (EHR), revealed the facility admitted the resident on 06/18/2021 with diagnoses to include traumatic subdural hemorrhage, muscle wasting and atrophy, and chronic pain.Review of the quarterly Minimum Data Set [MDS], found in R122's EHR with an Assessment Reference Date (ARD) of 12/26/2025, revealed the resident had a Brief Interview for Mental Status [BIMS] score of 15 out of 15, indicating the resident was cognitively intact. Further review revealed in the pain assessment interview the resident indicated she had frequent pain and was taking an opioid for pain.Review of the Order Summary Report, dated 01/2026 and found in R122's EHR, revealed on 04/18/2022 the physician ordered gabapentin capsule 300 milligrams (mg), give one capsule per mouth, three times a day related to pain.Review of the IPCSAR and MAR for gabapentin 300 mg one capsule by mouth three times daily at 8:00 AM, 2:00 PM, and 8:00 PM revealed repeated instances where the IPCSAR was not signed, the sign out time did not correlate with the MAR administration time, and multiple doses were administered outside the appropriate timeframe. Those incidents were on 01/02/2026, the 8:00 PM dose was signed out at 8:00 PM but administered at 10:48 PM, two hours and 48 minutes past the SAT; on 01/04/2026, the 8:00 AM dose was signed out at 8:23 AM but administered at 10:44 AM, two hours and 44 minutes past the SAT; on 01/06/2026, the 8:00 AM dose was signed out at 9:30 AM but administered at 1:04 PM, five hours and four minutes past the SAT; and the next scheduled dose (ordered every eight hours) was given at 2:17 PM, only one hour and 13 minutes later, shortening the ordered eight hour dosing interval by six hours and 47 minutes. Additionally, on 01/06/2026, the 8:00 PM dose was signed out at 8:00 PM but administered at 11:42 PM, three hours and 42 minutes past the SAT. On 01/07/2026, documentation indicated a dose at 10:20 AM; however, there was no corresponding IPCSAR sign out. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified the medication was administered outside the acceptable administration time frame of one hour before and one hour after the schedule administration time.During an interview with R122 on 01/07/2026 at 11:16 AM, she stated her pain was frequent and her pain medications were often not administered on schedule, particularly when certain nurses were working, but she could not recall specific staff names. She stated delayed doses caused her pain to worsen. She further stated she often waited a long time for her medications.2. Review of the admission Record found in R2's EHR, revealed the facility admitted the resident on 12/23/2025 with diagnoses to include chronic respiratory failure, generalized anxiety disorder, and chronic pain.Review of the quarterly MDS, found in R2's EHR with an ARD of 12/29/2025, revealed the resident had a BIMS score of 14 out of 15, indicating the resident was cognitively intact. Further review revealed in the pain assessment interview the resident indicated she had frequent pain and was taking opioids (pain reliever), antianxiety, and antipsychotic medications.Review of the Order Summary Report, dated 01/2026 and found in R2's EHR, revealed on 12/23/2025, the physician ordered lorazepam 1 milligram (mg), give one tablet per mouth, every eight hours related to generalized anxiety disorder. The medication was scheduled for 6:00 AM, 2:00 PM, and 10:00 PM.Review of R2's lorazepam 1 mg IPCSAR and corresponding MAR documentation revealed multiple discrepancies between medication administration times and controlled substance sign out documentation and administration outside the SAT. Those incidents were on 01/04/2026, the lorazepam was documented as signed out at 6:00 AM, but MAR documentation indicated it was administered at 5:44 AM, prior to being signed out; on 01/04/2026, MAR documentation indicated the 10:00 PM dose was administration at 11:21 PM, one hour and 21 minutes past the SAT, with no corresponding documented IPCSAR sign out; on 01/05/2026, MAR documentation indicated the 2:00 PM dose was administered at 5:36 PM, three hours and 36 minutes past the SAT, with no corresponding documented IPCSAR sign out; on 01/06/2026, the 10:00 PM dose was documented as signed out at 8:00 PM, but MAR documentation indicated administration at 10:44 PM; and on 01/07/2026, MAR documentation indicated administration at 5:15 AM, prior to the medication being signed out, and administration at 10:10 PM, with no corresponding documented IPCSAR sign out. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified the medication was administered outside the acceptable administration time frame.3. Review of the admission Record found in R17's EHR, revealed the facility admitted the resident on 07/11/2025 with diagnoses to include chronic obstructive pulmonary disease (COPD), respiratory failure, and chronic pain.Review of the quarterly MDS, found in R17 's EHR with an ARD of 09/26/2025, revealed the resident had a BIMS score of 15 out of 15, indicating the resident was cognitively intact. Further review revealed in the pain assessment interview the resident indicated he had frequent pain and was taking opioids for pain.Review of the Order Summary Report, dated 01/2026 and found in R17's EHR, revealed on 07/14/2025 the physician ordered gabapentin 100 mg, give 100 mg by mouth, three times per day related to chronic pain. The medication was scheduled for 8:00 AM, 2:00 PM, and 8:00 PM.Review of R17's gabapentin 100 mg MAR documentation revealed on 01/05/2026 the 8:00 PM dose was administered at 10:12 PM, two hours and 12 minutes past the SAT. Also, on 01/06/2026, the 8:00 AM dose was given at 10:21 AM, two hours and 21 minutes past the SAT. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified the medication was administered outside the acceptable administration time frame.4. Review of the admission Record found in R20's EHR, revealed the facility admitted the resident on 05/25/2023 with diagnoses to include acute kidney failure, anxiety disorder, and unspecified dementia.Review of the quarterly MDS, found in R20's EHR with an ARD of 09/26/2025, revealed the resident had a BIMS score of zero out of 15, indicating the resident had severe cognitive impairment. Further review revealed that R20 was taking antianxiety medication.Review of the Order Summary Report, dated 01/2026, and found in R20's EHR, revealed on 12/19/2025 the physician ordered lorazepam 0.5 mg, give 1 by mouth, two times a day related to anxiety. The medication was scheduled for 9:00 AM and 9:00 PM.Review of R20's lorazepam 0.5 mg IPCSAR and corresponding MAR documentation revealed on 01/01/2026, the 9:00 AM dose was documented as signed out at 1:28 PM, and MAR documentation indicated it was administered at 1:28 PM, four hours and 28 minutes past the SAT. The next scheduled dose (ordered every 12 hours) was given at 9:18 PM, only seven hours and 50 minutes later, shortening the ordered 12-hour dosing interval by 4 hours and 10 minutes. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified that the medication was administered outside the acceptable administration time frame.5. Review of the admission Record found in R23's EHR, revealed the facility admitted the resident on 06/30/2025 with diagnoses to include diffuse traumatic brain injury, muscle wasting and atrophy, and hemiplegia.Review of the quarterly MDS, found in R23 's EHR with an ARD of 12/28/2025, revealed the resident had a BIMS score of nine out of 15, indicating the resident had moderate cognitive impairment and was taking opioids for pain.Review of the Order Summary Report, dated 01/2026 and found in R23's EHR, revealed on 09/19/2025 the physician ordered morphine sulfate oral solution 20 mg/milliliter (mL), give 0.25 mL three times a day for pain related to muscle wasting and atrophy. The medication was scheduled for 8:00 AM, 2:00 PM, and 8:00 PM.Review of R23's morphine sulfate oral solution 20 mg/mL IPCSAR and corresponding MAR documentation revealed multiple discrepancies between medication administration times and controlled substance sign out documentation for the 8:00 AM dose. On 12/28/2025, it was signed out on the IPCSAR at 8:00 AM, but the MAR indicated the medication was not administered until 10:25 AM, two hours and 25 minutes past the SAT; on 12/29/2025, it was signed out on the IPCSAR at 8:15 AM, but the MAR indicated the medication was not administered until 10:36 AM, two hours and 36 minutes past the SAT; on 12/31/2025, it was signed out on the IPCSAR at 8:30 AM, but the MAR indicated the medication was not administered until 11:18 AM, three hours and 18 minutes past the SAT; and on 01/02/2026, it was signed out on the IPCSAR at 8:30 AM, but the MAR indicated the medication was not administered until 10:04 AM, two hours and four minutes past the SAT. Further review revealed for the 2:00 PM dose, on 12/31/2025, it was signed out on the IPCSAR at 3:30 PM, but the MAR indicated the medication was administered at 5:33 PM, three hours and 33 minutes past the SAT. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified that the medication was administered outside the acceptable administration time frame.6. Review of the admission Record found in R31's EHR revealed the facility admitted the resident on 10/27/2021 with diagnoses to include cerebral infarction, chronic obstructive pulmonary disease (COPD), and chronic pain.Review of the quarterly MDS, found in R31 's EHR with an ARD of 12/28/2025, revealed the resident had a BIMS score of nine out of 15, indicating the resident had moderate cognitive impairment. Further review revealed R31 was taking antipsychotics and opioids.Review of the Order Summary Report, dated 01/2026 and found in R31's EHR, revealed on 11/24/2025 the physician ordered hydrocodone-acetaminophen 5-325 mg tablet, give one tablet by mouth every six hours. The medication was scheduled for 2:00 AM, 8:00 AM, 2:00 PM, and 8:00 PM.Review of R31's hydrocodone-acetaminophen 5-325 mg IPCSAR and corresponding MAR documentation revealed multiple discrepancies between medication administration times and controlled substance sign out documentation and administration past the SAT. Those instances, for the 8:00 dose, were on 01/01/2026, it was documented as administered at 11:42 AM, three hours and 42 minutes past the SAT; on 01/04/2026, it was documented as administered at 11:10 AM, three hours and 10 minutes past the SAT; and on 01/06/2026, it was documented as administered at 10:34 AM, two hours and 34 minutes late, while the IPCSAR reflected a sign out at 7:00 AM. For the 2:00 PM dose, on 01/01/2026, it was documented as administered at 3:47 PM, one hour and 47 minutes past the SAT, and there was no provided IPCSAR sign out for that dose; and on 01/04/2026, it was documented as being administered at 7:00 PM, five hours past the SAT. Also, on 01/04/1026, the 8:00 PM dose was documented as administered at 8:40 PM, one hour and 40 minutes from the previously documented dose. On 01/05/2026, the 8:00 PM dose was documented as administered at 10:07 PM, two hours and seven minutes past the SAT. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified that the medication was administered outside the acceptable administration time frame.7. Review of the admission Record found in R37's EHR revealed the facility admitted the resident on 04/24/2025 with diagnoses to include Alzheimer's disease, chronic kidney disease stage 3, and muscle wasting and atrophy.Review of the quarterly MDS, found in R37's EHR with an ARD of 12/27/2025, revealed the resident had a BIMS score of five out of 15, indicating the resident had severe cognitive impairment. Further review revealed that R37 was taking opioids.Review of the Order Summary Report, dated 01/2026 and found in R37's EHR, revealed on 05/23/2025 the physician ordered hydrocodone-acetaminophen 5-325 mg tablet, give one tablet by mouth every six hours. The medication was scheduled for 6:00 AM, 12:00 PM, 6:00 PM, and 12:00 PM.Review of R37's hydrocodone-acetaminophen 5-325 mg IPCSAR and corresponding MAR documentation revealed multiple discrepancies between medication administration times and controlled substance sign out documentation. On 01/01/2026, 01/04/2026, and 01/05/2026, the 6:00 AM doses were all documented on the IPCSAR at 6:00 AM after the medication had already been administered, indicating late controlled substance documentation rather than real time sign out. Additionally, on 01/01/2026, the 6:00 PM dose was administered at 5:02 PM but was not signed out on the IPCSAR until 6:00 PM, reflecting delayed controlled-substance documentation.8. Review of the admission Record found in R42's EHR, revealed the facility admitted the resident on 12/01/2025 with diagnoses to include hemiplegia, type 2 diabetes with diabetic neuropathy, and unspecified pain.Review of the quarterly MDS, found in R42's EHR with an ARD of 12/07/2025, revealed the resident had a BIMS score of 12 out of 15, indicating the resident had moderate cognitive impairment. Further review revealed in the pain assessment interview, the resident indicated she had frequent pain.Review of the Order Summary Report, dated 01/2026 and found in R42's EHR, revealed on 12/01/2025 the physician ordered gabapentin oral tablet, give 300 mg by mouth two times a day related to pain. The medication was scheduled for 8:00 AM and 8:00 PM.Review of R42's gabapentin 300 mg oral tablet IPCSAR and corresponding MAR documentation revealed multiple late medication administrations. The instance for the 8:00 AM dose was on 01/07/2026, when it was administered at 11:24 AM, three hours and 24 minutes past the SAT and signed out on the IPCSAR at 11:00 AM. Instances for the 8:00 PM dose were on 01/03/2026, when it was documented as administered on 01/04/2026 at 1:21 AM, five hours and 21 minutes past the SAT, leaving an approximate six and one-half hour window between the next scheduled dose, and a corresponding IPCSAR was not provided; on 01/04/2026, it was documented as administered at 11:24 PM, three hours and 24 minutes past the SAT, and signed out on the IPCSAR at 11:00 PM; and on 01/07/2026, it was administered at 10:42 AM, two hours and 42 minutes late past the SAT and signed out at 10:42 PM. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified that the medication was administered outside the acceptable administration time frame.9. Review of the admission Record found in R68's EHR, revealed the facility admitted the resident on 07/24/2024 with diagnoses to include end stage renal disease (ESRD), pain in left ankle and joints of the left foot and shoulder pain, and Achilles tendinitis.Review of the quarterly Minimum Data Set [MDS], found in R68 's EHR with an ARD of 12/16/2025, revealed the resident had a BIMS score of 11 out of 15, indicating the resident had moderate cognitive impairment. Further review revealed in the pain assessment interview, the resident indicated she had frequent pain and was taking opioids (pain reliever) for pain.Review of the Order Summary Report, dated 01/2026 and found in R68's EHR, revealed on 10/10/2025 the physician ordered pregabalin capsule 100 mg, give one capsule per mouth, two times a day every Monday, Wednesday, and Friday at 9:00 AM and 9:00 PM, related to low back pain. In 12/2024 she was ordered oxycodone-acetaminophen 5-325 mg, give one tablet by mouth at 6:00 AM and 2:00 PM and oxycodone-acetaminophen 5-325 mg, give two tablets by mouth at bedtime (scheduled for 9:00 PM). Those orders were discontinued on 01/08/2026. A new order was received, dated 01/09/2025, for oxycodone-acetaminophen 5-325 mg, give two tablets by mouth at bedtime (scheduled for 10:00 PM). Additionally, R68 had an order for alprazolam 1 mg, give one tablet twice daily, at 9:00 AM and 9:00 PM.Review of the MAR, dated 12/2025 and found in R68's EHR, revealed her ordered pregabalin 100 mg capsule for 9:00 AM was administered on 12/29/2025 at 10:53 AM, one hour and 53 minutes past the SAT. Further review revealed her 2:00 PM dose for oxycodone-acetaminophen 5-325 mg tablets was administered on 12/27/2025 at 4:11 PM, two hours and 11 minutes past the SAT; and on 12/29/2025 it was given at 6:14 PM, four hours and 14 minutes past the SAT. Further review revealed R68's 9:00 AM dose for alprazolam 1 mg, on 12/22/2025, was given at 11:52 AM, two hours and 52 minutes past the SAT; on 12/29/2025, it was given at 10:54 AM, one hour and 54 minutes past the SAT; and on 12/30/2025, it was given at 11:22 AM, two hours and 22 minutes past the SAT. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified that the medication was administered outside the acceptable administration time frame.During an interview with R68 on 01/13/2026 at 9:10 AM, she stated her medications were frequently administered late. R68 stated that delays in her pain and anxiety medications led to a return of pain and escalation of anxiety. She stated, once her medications were not given on time, it was hard for her symptoms to settle back to a tolerable level. She further stated, recently, there were several incidents when her pain and anxiety medication were not given at the ordered time. She stated, although she could not recall the specific dates or times, delayed doses increased her anxiety and made it harder to cope with her chronic pain.10. Review of the admission Record found in R73's EHR, revealed the facility admitted the resident on 07/22/2024 with diagnoses to include chronic pain syndrome, peripheral vascular osteomyelitis, and peripheral disease. Review of the quarterly MDS, found in R73's EHR with an ARD of 12/23/2025, revealed the resident had a BIMS score of 15 out of 15, indicating the resident was cognitively intact. Further review revealed in the pain assessment interview, the resident indicated he had pain almost constantly and was taking opioids (pain reliever) for pain.Review of the Order Summary Report, dated 01/2026 and found in R73's EHR, revealed on 11/14/2025 the physician ordered gabapentin capsule 300 mg, give one capsule per mouth, three times a day related to peripheral vascular disease and oxycodone HCL oral tablet, 15 mg, give by mouth every four hours as needed for pain related to chronic pain syndrome.Review of the MAR, dated 01/2026 and found in R73's EHR, revealed his ordered gabapentin 300 mg capsule for the 8:00 AM dose was administered on 01/03/2026 at 11:17 AM, three hours and 17 minutes past the SAT; on 01/04/2026, it was given at 10:45 AM, two hours and 45 minutes past the SAT; on 01/05/2026, it was given at 9:52 AM, one hour and 52 minutes past the SAT; and on 01/09/2026, it was given at 11:25 AM, three hours and 25 minutes late. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified that the medication was administered outside the acceptable administration time frame.During an interview with R73 on 01/13/2026 at 9:20 AM, he stated there had been several times when his medications had not been administered on schedule during the last couple weeks. He stated, when his pain medications were given late, his pain intensified and required significant time to return to baseline. He further stated it was more common than not for his pain medications to be administered late. Additionally, he stated he typically waited at least one hour past the scheduled administration time and sometimes, on occasion, he waited two hours or longer.During an interview with LPN1 on 01/14/2026 at 3:30 PM, she stated the medication window was one hour before and one hour after the scheduled ordered time. She stated staff was taught to sign out medications when removed from the cart and complete remaining medication administration record documentation after administration. When asked why several of R73's gabapentin 300 milligrams, ordered three times a day, were administered outside the facility's administration window during her medication administrations, LPN1 stated interruptions and short staffing could cause some medication administration to run late. She further stated documentation could be delayed, and there were too many medications assigned to one cart. LPN1 stated it was important to follow the resident's plan of care and provide ordered medication on schedule to ensure timely administration and documentation to prevent the residents from experiencing prolonged or increased pain. 11. Review of the admission Record found in R127's EHR, revealed the facility admitted the resident on 01/02/2025 with diagnoses to include chronic pain syndrome, Parkinson's disease, anxiety and panic disorder, and pain.Review of the quarterly MDS, found in R127's EHR with an ARD of 10/11/2025, revealed the resident had a BIMS score of 11 out of 15, indicating the resident had moderate cognitive impairment. Further review revealed in the pain assessment interview, the resident indicated she had pain frequently and was taking antianxiety medications and opioids for pain.Review of the Order Summary Report, dated 01/2026, and found in R127's EHR, revealed on 01/02/2025 the physician ordered clonazepam (brand name Klonopin) oral tablet 1 mg, give one tablet every 12 hours related to anxiety disorder and hydrocodone-acetaminophen (brand name Norco) 5-325 mg oral tablet, give one tablet by mouth every 12 hours for pain management.Review of the MAR, dated 12/2025 and 01/2026 and found in R127's EHR, revealed, for the hydrocodone-acetaminophen 5-325 mg oral tablet for 8:00 AM, on 01/04/2026, it was given at 10:25 AM, two hours and 25 minutes past the SAT; and on 01/11/2026, it was administered at 10:19 AM, two hours and 19 minutes past the SAT. Further review revealed for the hydrocodone-acetaminophen 5-325 mg oral tablet for 8:00 PM, on 12/31/2026, it was given at 10:30 PM, two hours and 30 minutes past the SAT; on 01/01/2026, it was given at 12:39 AM, the following day, four hours and 39 minutes past the SAT; and on 01/04/2026, it was given at 10:00 PM, two hours past the SAT. Review of the MAR, dated 01/2026 and found in 127's EHR, revealed, for the clonazepam 1 mg tablet 9:00 AM dose, on 01/01/2026, it was administered at 12:33 PM, three hours and 33 minutes past the SAT; and on 01/05/2026, it was administered at 10:13 AM, one hour and 13 minutes past the SAT. For the 9:00 PM dose, on 01/02/2026, it was administered at 10:03 PM, one hour and three minutes past the SAT; and on 01/04/2026, it was administered at 10:10 PM, one hour and 10 minutes past the SAT. Continued review of the MAR documentation revealed no corresponding note to indicate the physician was notified that the medication was administered outside the acceptable administration time frame.During an interview with R127 on 01/12/2026 at 12:50 PM, she stated she received routine pain medication. However, she stated her medications were late yesterday morning (01/11/2026). R127 stated she was supposed to receive her medications at 9:00 AM, but it was close to 10:25 AM before she received them yesterday.During an interview with State Trained Nurse Aide/Kentucky Medication Aide (STNA/KMA) 14 on 01/15/2025 at 2:12 PM, when asked about delayed medication administration for R127's Norco and Klonopin on 01/01/2026, scheduled for 9:00 AM but documented as administered at approximately 12:33 PM, she stated she did not recall specific circumstances that caused the delay. STNA/KMA14 initially stated the unit was well staffed. However, she stated later she took over the medication cart two hours into her shift due to a nurse call-in. When asked about notifying the physician, she stated KMA's typically did not have access to the facility application used for provider communications. She stated it would be the supervisor's responsibility to notify the on-call provider if needed.During an interview with Licensed Practical Nurse (LPN) 6 on 01/08/2026 at 1:30 PM, he stated nursing staff was not to sign out medications early or late, and documentation must reflect the actual administration process. He stated the concern with failure to document in real-time was that it resulted in errors, raised concern whether the medication was actually administered to the resident, and created potential for diversion. He stated inaccurate documentation was not legal and was not consistent with standard nursing practice.During an interview with LPN14 on 01/08/2026 at 1:55 PM, she stated real-time documentation ensured residents received medications correctly and at the appropriate time. She stated if she observed documentation suggesting a medication scheduled at 8:00 AM was documented as removed at 12:00 PM and the next scheduled dose was due at 2:00 PM, she would follow the chain of command by notifying the Unit Manager or Director of Nursing (DON), hold the dose, and contact the physician for guidance because the doses would be too close together.During an interview with LPN16 on 01/08/2026 at 2:20 PM, she stated nursing staff should sign out controlled medications on the MAR and the IPCSAR at the same time the medication was administered.During an interview with Nurse Supervisor/LPN13 on 01/08/2026 at 2:20 PM, she stated she was the nurse supervisor responsible for building oversight, staffing, walkthroughs, and monitoring resident care. She stated the controlled narcotic sheet [IPCSAR] and MAR audits were typically completed by the DON and were not usually part of her role. She stated her expectation was that medications be removed, administered, and documented at the time of administration. She further stated, if a dose was administered beyond the one-hour allowance, staff should notify the physician for direction and notify the DON.During an interview with LPN5 on 01/09/2026 at 10:15 AM, she stated the expected process was to verify the correct medication, sign out the controlled substance at the time it was removed [on the IPCSAR], administer it to the resident, and document administration on the MAR. She stated any significant delay or discrepancy between sign out and administration should be reported to the physician and explained in a nurse's note. She stated accurate documentation was necessary to prevent missing narcotics and support timely medication administration.During an interview with the contracted pharmacy's Registered Pharmacist (RPh) on 01/10/2026 at 1:50 PM, he stated nursing staff should administer medications according to physician orders and within the required administration window, so doses were appropriately spaced, and therapeutic levels were maintained. He stated, A medication's half-life is the time it takes for the amount of the drug in the body to decrease by 50 percent and giving a dose late can result in residual medication still present when the next scheduled dose is due, increasing risk for unintended dose stacking, accidental double dosing or overdose. The RPh further stated the physician should be notified when a medication was administered late because some drugs, including gabapentin, have an elimination half-life of approximately five to seven hours in residents with normal kidney function. He stated, in residents with decreased renal function, the half-life could be significantly prolonged, which increased the risk of accumulation and adverse effects when doses were given late or too close together.During an interview with the DON on 01/15/2025 at 4:10 PM, she stated she reviewed only a limited sample of IPCSAR sheets and did not reconcile the IPCSAR sign-out times with the corresponding MAR administration times. She stated her review was limited to IPCSAR completion, and as a result, she was not aware of the extent of the inconsistencies. The DON stated it was her expectation that nursing staff complied with the facility policy requiring medications to be administered within the one-hour medication administration window. Additionally, she stated it was her expectation that nursing staff signed the IPCSAR at the time the controlled substance was removed from the bubble pack and administered promptly, then documented appropriately. During an interview with the Administrator on 01/15/2025 at 4:10 PM, she stated licensed clinical staff was expected to follow facility policies, administer medications timely, and communicate delays appropriately. The Administrator stated she could not speak to each specific late administration event without reviewing the details and whether legitimate circumstances were present. The Administrator stated controlled substance documentation and medication administration practices had improved significantly, stating the facility went from a high percentage of incorrect signatures/documentation to substantially fewer errors. The Administrator clarified prior monitoring was limited (e.g., auditing a limited number of individuals per medication cart), and the facility was now auditing all staff by pulling MARs and comparing medication administration details across shifts.During continued interview with the Administrator on 01/15/2025 at[TRUNCATED]